205 related articles for article (PubMed ID: 23901348)
1. CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells.
Lazarova DL; Chiaro C; Wong T; Drago E; Rainey A; O'Malley S; Bordonaro M
J Cancer; 2013; 4(6):481-90. PubMed ID: 23901348
[TBL] [Abstract][Full Text] [Related]
2. p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells.
Lazarova DL; Wong T; Chiaro C; Drago E; Bordonaro M
J Cancer; 2013; 4(6):491-501. PubMed ID: 23901349
[TBL] [Abstract][Full Text] [Related]
3. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
Bordonaro M; Lazarova DL
World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
[TBL] [Abstract][Full Text] [Related]
4. Hypothesis: Sam68 and Pygo2 mediate cell type-specific effects of the modulation of CBP-Wnt and p300-Wnt activities in Colorectal Cancer Cells.
Bordonaro M
J Cancer; 2021; 12(16):5046-5052. PubMed ID: 34234873
[TBL] [Abstract][Full Text] [Related]
5. Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells.
Bordonaro M; Lazarova DL
JMIR Res Protoc; 2016 May; 5(2):e66. PubMed ID: 27177606
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Wnt Activity and Cell Physiology by Butyrate in LT97 Microadenoma Cells.
Lazarova D; Lee A; Wong T; Marian B; Chiaro C; Rainey C; Bordonaro M
J Cancer; 2014; 5(3):203-13. PubMed ID: 24563675
[TBL] [Abstract][Full Text] [Related]
7. ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.
Lazarova D; Bordonaro M
J Cancer; 2017; 8(8):1453-1459. PubMed ID: 28638460
[TBL] [Abstract][Full Text] [Related]
8. A switch from canonical to noncanonical Wnt signaling mediates drug resistance in colon cancer cells.
Bordonaro M; Tewari S; Cicco CE; Atamna W; Lazarova DL
PLoS One; 2011; 6(11):e27308. PubMed ID: 22073312
[TBL] [Abstract][Full Text] [Related]
9. Further analysis of p300 in mediating effects of Butyrate in Colorectal Cancer Cells.
Bordonaro M
J Cancer; 2020; 11(20):5861-5866. PubMed ID: 32922528
[TBL] [Abstract][Full Text] [Related]
10. The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors.
Bordonaro M; Lazarova DL; Sartorelli AC
Exp Cell Res; 2007 May; 313(8):1652-66. PubMed ID: 17359971
[TBL] [Abstract][Full Text] [Related]
11. p300 Knockout Promotes Butyrate Resistance.
Lazarova DL; Bordonaro M
J Cancer; 2017; 8(17):3405-3409. PubMed ID: 29151923
[TBL] [Abstract][Full Text] [Related]
12. Hypothesis: Retinoblastoma protein inactivation mediates effects of histone deacetylase inhibitor-induced Wnt hyperactivation in colorectal cancer cells.
Bordonaro M
J Cancer; 2020; 11(3):668-677. PubMed ID: 31942190
[TBL] [Abstract][Full Text] [Related]
13. Vimentin, colon cancer progression and resistance to butyrate and other HDACis.
Lazarova DL; Bordonaro M
J Cell Mol Med; 2016 Jun; 20(6):989-93. PubMed ID: 27072512
[TBL] [Abstract][Full Text] [Related]
14. Hyperinduction of Wnt activity: a new paradigm for the treatment of colorectal cancer?
Bordonaro M; Lazarova DL; Sartorelli AC
Oncol Res; 2008; 17(1):1-9. PubMed ID: 18488710
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic and Receptor-Mediated Wnt Signaling Influence the Sensitivity of Colonic Cells to Butyrate.
Bordonaro M
J Cancer; 2023; 14(3):446-453. PubMed ID: 36860917
[TBL] [Abstract][Full Text] [Related]
16. Altering cancer transcriptomes using epigenomic inhibitors.
Gaddis M; Gerrard D; Frietze S; Farnham PJ
Epigenetics Chromatin; 2015; 8():9. PubMed ID: 26191083
[TBL] [Abstract][Full Text] [Related]
17. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
[TBL] [Abstract][Full Text] [Related]
18. [Fiber, cancer stem cells, and the Wnt signaling continuum: possibilities for colorectal cancer prevention and therapeutics].
Bordonaro M; Sartorelli AC
Ai Zheng; 2008 Jul; 27(7):766-70. PubMed ID: 18606074
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive suppression of all apoptosis-induced proliferation pathways as a proposed approach to colorectal cancer prevention and therapy.
Bordonaro M; Drago E; Atamna W; Lazarova DL
PLoS One; 2014; 9(12):e115068. PubMed ID: 25500581
[TBL] [Abstract][Full Text] [Related]
20. Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma.
Brkic FF; Stoiber S; Maier T; Gurnhofer E; Kenner L; Heiduschka G; Kadletz-Wanke L
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
